Bepridil has been shown to inhibit NOTCH1 in CLL cells more specifically than gamma secretase inhibitors (GSI), whose effects also impact NOTCH2 [16]. The gene discussed is NOTCH1; the disease is B-cell chronic lymphocytic leukemia.